Literature DB >> 26013805

ExPLAining early synucleinopathies.

Ulf Dettmer1, Tim Bartels2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26013805      PMCID： PMC4614127          DOI： 10.1093/brain/awv099

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  11 in total

1.  Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.

Authors:  J Fuchs; C Nilsson; J Kachergus; M Munz; E-M Larsson; B Schüle; J W Langston; F A Middleton; O A Ross; M Hulihan; T Gasser; M J Farrer
Journal:  Neurology       Date:  2007-01-24       Impact factor: 9.910

2.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

3.  In vivo cross-linking reveals principally oligomeric forms of α-synuclein and β-synuclein in neurons and non-neural cells.

Authors:  Ulf Dettmer; Andrew J Newman; Eric S Luth; Tim Bartels; Dennis Selkoe
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

4.  α-synuclein multimers cluster synaptic vesicles and attenuate recycling.

Authors:  Lina Wang; Utpal Das; David A Scott; Yong Tang; Pamela J McLean; Subhojit Roy
Journal:  Curr Biol       Date:  2014-09-25       Impact factor: 10.834

5.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

6.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

Review 7.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

8.  Prevalence of Parkinson's disease in the elderly: the Rotterdam Study.

Authors:  M C de Rijk; M M Breteler; G A Graveland; A Ott; D E Grobbee; F G van der Meché; A Hofman
Journal:  Neurology       Date:  1995-12       Impact factor: 9.910

9.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.

Authors:  Tim Bartels; Joanna G Choi; Dennis J Selkoe
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

10.  Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain.

Authors:  Rosalind F Roberts; Richard Wade-Martins; Javier Alegre-Abarrategui
Journal:  Brain       Date:  2015-03-01       Impact factor: 13.501
View more
  2 in total

Review 1.  Cellular models of alpha-synuclein toxicity and aggregation.

Authors:  Marion Delenclos; Jeremy D Burgess; Agaristi Lamprokostopoulou; Tiago F Outeiro; Kostas Vekrellis; Pamela J McLean
Journal:  J Neurochem       Date:  2019-07-30       Impact factor: 5.372

Review 2.  Alpha-synuclein oligomers: a new hope.

Authors:  Nora Bengoa-Vergniory; Rosalind F Roberts; Richard Wade-Martins; Javier Alegre-Abarrategui
Journal:  Acta Neuropathol       Date:  2017-08-12       Impact factor: 17.088
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.